Guardant Infinity is a single platform that can both
quantify and characterize cancer with genomic and epigenomic analysis, powering multiple applications in precision oncology.

Quantify cancer

Monitor and measure cancer across
the continuum of care

Methylation-based quantification of tumor fraction to measure disease burden.

Characterize cancer

Genomic and epigenomic profiling

Unrivaled discovery power that combines genomic and epigenomic profiling for multidimensional insights.

Get a more
complete view
of cancer with
Guardant Infinity.

Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma